Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Dose Regimens for Preventing Uterine Atony and Postpartum Hemorrhage
NCT00790062Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2008
- Primary completion
- Jun 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin in uterine atony, postpartum hemorrhage (PPH), sponsored by University of Alabama at Birmingham. Started Nov 2008; status: completed.
02
Drugs
oxytocin
03
Conditions
uterine atonypostpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT00790062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790062.